FDA Inspection 1220500 - Biogen U.S. Corporation - October 17, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Biogen U.S. Corporation, with an inspection on October 17, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Biogen U.S. Corporation
Inspection Date: October 17, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 900286c7-188d-48a4-afa8-5f32b90599d4

Violation Codes5

21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.160(b)21 CFR 211.19221 CFR 211.198(a)

Full citation text and observation details available on the Dashboard.